1. Development of Heat Shock Protein (Hsp90) Inhibitors To Combat Resistance to Tyrosine Kinase Inhibitors through Hsp90–Kinase Interactions
   Meining Wang et al, 2016, Journal of Medicinal Chemistry CrossRef
2. Anticancer s-Triazine Derivatives: A Synthetic Attribute
   Sonika Jain et al, 2020, Mini-Reviews in Organic Chemistry CrossRef
3. Mutant p53, Stabilized by Its Interplay with HSP90, Activates a Positive Feed-Back Loop Between NRF2 and p62 that Induces Chemo-Resistance to Apigenin in Pancreatic Cancer Cells
   Maria Saveria Gilardini Montani et al, 2019, Cancers CrossRef
4. Emerging Link between Tsc1 and FNIP Co-Chaperones of Hsp90 and Cancer
   Sarah J. Backe et al, 2022, Biomolecules CrossRef
5. Mutant p53 and Cellular Stress Pathways: A Criminal Alliance That Promotes Cancer Progression
   Gabriella D’Orazi et al, 2019, Cancers CrossRef
6. The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease
   Shirin V. Sundar et al, 2022, American Journal of Physiology-Renal Physiology CrossRef
7. Transferrin Modified GSH Sensitive Hyaluronic Acid Derivative Micelle to Deliver HSP90 Inhibitors to Enhance the Therapeutic Efficacy of Brain Cancers
   Tilahun Ayane Debele et al, 2021, Cancers CrossRef
8. Hsp90 in Human Diseases: Molecular Mechanisms to Therapeutic Approaches
   Mamta P. Sumi et al, 2022, Cells CrossRef
9. Inhibition of HSP90 Promotes Neural Stem Cell Survival from Oxidative Stress through Attenuating NF-κB/p65 Activation
   Qian Liu et al, 2016, Oxidative Medicine and Cellular Longevity CrossRef
10. Inhibitors of HSP90 in melanoma
    Aleksandra Mielczarek-Lewandowska et al, 2020, Apoptosis CrossRef
11. Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer
    Milad Ashrafizadeh et al, 2020, Frontiers in Chemistry CrossRef